News, Analysis & Insights on Nutrition, Supplements, and Health
Neptune Technologies and Bioressources says the US Patent & Trademark Office (USPTO) has allowed a continuation patent application that strengthens claims in its recently-awarded US patent #8,030,348.
An natural ingredient found in milk could protect humans against obesity, even while enjoying a diet high in fat, research has found.
Increased intakes of omega-3s and higher blood levels of the fatty acids are associated with a 15% decrease in the risk of heart failure, says a new meta-analysis.
DISPATCHES FROM VITAFOODS EUROPE 2012
The functional food and nutritional supplement industry must tackle the key issues of anti-ageing in a ‘much more comprehensive’ way than it currently does, warns leading ageing expert.
Schiff Nutrition’s decision to pump all available cash into branding and innovation instead of deep discounts has paid off for its Move Free joint care brand, with posted a 25% surge in sales in the third quarter in a category that was “basically flat”,...
Dispatches from Vitafoods Europe 2012
Omega-3 suppliers must get to grips with their manufacturing customers and with consumers if they are to market their products successfully, according to Virpi Varjonen, executive consultant at commercialisation agents Invenire.
Dispatches from Vitafoods Europe 2012
South Korea is Asia’s fastest growing omega-3 market underpinned by new government legislation with high recommended daily intake (RDI) levels but China and Indonesia also hold potential, according to executive director of GOED.
Dispatches from Vitafoods Europe 2012
The new chief of Frutarom’s Health Division says the Israeli-Swiss flavours, fragrances and ingredients firm can learn something about ‘concept marketing’ from the many years he spent at former employer, BASF-Cognis.
Daily supplements of vitamin C may decrease heart rate during exercise and reduce the perception of fatigue and exertion, suggests new data.
A ‘mega-healthy’ airline meal has been created by Leatherhead Food Research (LFR), which satisfies all 222 Article 13.1 health claims approved by the European Commission (EC) last month.